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Abstract
Background: Wrist blood pressure (BP) devices have physiological limits with regards to accuracy,
therefore they were not preferred for home BP monitoring. However some wrist devices have been
successfully validated using etablished validation protocols. Therefore this study assessed the
reproducibility of wrist home BP measurement with position sensor and automatic data storage.
Methods: To compare the reproducibility of three different(BP) measurement methods: 1) office BP, 2)
home BP (Omron wrist device HEM- 637 IT with position sensor), 3) 24-hour ambulatory BP(24-h ABPM)
(ABPM-04, Meditech, Hun)conventional sphygmomanometric office BP was measured on study days 1 and
7, 24-h ABPM on study days 7 and 14 and home BP between study days 1 and 7 and between study days
8 and 14 in 69 hypertensive and 28 normotensive subjects. The correlation coeffcient of each BP
measurement method with echocardiographic left ventricular mass index was analyzed. The schedule of
home readings was performed according to recently published European Society of Hypertension (ESH)-
guidelines.
Results: The reproducibility of home BP measurement analyzed by the standard deviation as well as the
squared differeces of mean individual differences between the respective BP measurements was
significantly higher than the reproducibility of office BP (p < 0.001 for systolic and diastolic BP) and the
reproducibility of 24-h ABPM (p < 0.001 systolic BP, p = 0.127 diastolic BP). The reproducibility of systolic
and diastolic office versus 24-h ABPM was not significantly different (p = 0.80 systolic BP, p = 0.1 diastolic
BP). The correlation coefficient of 24-h ABMP (r = 0.52) with left ventricular mass index was significantly
higher than with office BP (r = 0.31). The difference between 24-h ABPM and home BP (r = 0.46) was not
significant.
Conclusion: The short-term reproducibility of home BP measurement with the Omron HEM-637 IT
wrist device was superior to the reproducibility of office BP and 24- h ABPM measurement. Furthermore,
home BP with the wrist device showed similar correlations to targed organ damage as recently reported
for upper arm devices. Although wrist devices have to be used cautious and with defined limitations, the
use of validated devices with position sensor according to recently recommended measurement schedules
might have the potential to be used for therapy monitoring.
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Background
The reproducibility of office blood pressure (office BP)
measurement in clinical studies as well as in doctor's
offices is very limited for various reasons. These include
for example observer bias, the white-coat and placebo
effects [1]. The poor reproducibility of office BP means
that a much larger number of patients must be included
in clinical pharmacological studies owing to the high
individual variability between two office BP measure-
ments. This is a prerequisite for demonstrating for exam-
ple the therapeutic effects of antihypertensive agents.
Incontestably, the ambulatory 24-hour blood pressure
measurement (24-h ABPM) shows much better reproduc-
ibility than the office BP measurements [2]. As a result of
the larger number of measurements and the better stand-
ardization, the 24-h ABPM reflects end organ damage bet-
ter than office BP, for example left ventricular hypertrophy
[3]. Multiple self-measurements carried out by the
patients at their home (home BP) improve the reproduci-
bility of blood pressure measurements substantially com-
pared to office BP [4]. The development of more precise
measurement technologies, clinical validation protocols
as well as increasing standardization of the measurement
technique and the measurement protocol can raise the
reproducibility of home BP measurements even further
[5]. BP measurement in the wrist provides several advan-
tages especially when performed by the patient at home.
For example, it does not require taking off clothes for cuff
application, the cuff can be applied more easily, and the
readings are less sensitive to obesity because wrist size is
little affected by obesity [6]. On the other hand accuracy
of wrist devices may be limited by several factors such as
anatomy of the wrist and arteriosclerotic vascular changes
as pointed out in a recent paper by Kikuya et al [7].
It has so far been unclear whether the reproducibility of
home BP measurement on the wrist is comparable with
that of 24-hour on the upper arm. Moreover, there have
been as yet not been any studies investigating the correla-
tion of wrist measurements with end organ damage such
as left ventricular hypertrophy.
In the present study, the following questions were there-
fore investigated with the Omron wrist instrument HEM-
637 IT with a position sensor:
1. To what extent is the short-term reproducibility of wrist
measurements with a position sensor comparable with
that of 24-h ABPM and office BP measurement?
2. How do multiple wrist measurements correlate with left
ventricular mass index (LVMI) as compared to 24-h ABPM
and office BP measurement?
Methods
The objective of the study was to investigate the reproduc-
ibility of office BP, home BP and 24-h ABPM over a period
of one week. For this purpose, an office BP measurement
was taken on study days 1 and 7 in 101 patients and an
ambulatory 24-h ABPM was carried out on study days 7
and 14. In the time intervals between study days 1 and 7
and between study days 8 and 14, the patients measured
their home BP themselves with an oscillometric wrist
instrument.
Study population
One hundred and one participants were included in the
study. All subjects were consecutively recruited from the
outpatients of Medical Policlinic of the University of
Bonn.
The data of 97 patients with complete data sets (55 men
and 42 women, 69 participants with office-measured
hypertension, 28 with office-measured normotension, 23
participants with antihypertensive treatment and 74 with-
out treatment) were included in the statistical analysis.
Hypertensive subjects measured home BP before taking
antihypertensive medication. The antihypertensive treat-
ment regime (frequency and timing) was not changed
during the study period. 4 patients were excluded. The
inclusion criteria were aged between 18 and 75 years and
the presence of written consent to participate in the study.
The exclusion criteria were significant arrhythmias, preg-
nancy and lactation. The University of Bonn issued a pos-
itive ethical vote on the study.
Methods of blood pressure measurement
1. Office blood pressure measurement (office BP)
The blood pressure was measured in the doctor's office in
accordance with the recommendations of the American
Heart Association (AHA) and the European Society of
Hypertension (ESH) after the participant had rested for
five minutes in a sitting position [6,8]. On study day 1,
two measurements per upper arm were made with a two-
minute interval between each measurements with the aus-
cultatory blood pressure instrument from Acuson (Acu-
son Greenlight 300 with universal cuff). Office BP was
measured with the same procedure only on the left upper
arm on study day 7. The office BP was taken with a preci-
sion nearest 2 mmHg.
2. Blood pressure self-measurement (home BP)
The patients measured their blood pressure themselves
with the oscillometric wrist instrument from Omron
(wrist instrument HEM- 637 IT with position sensor).
Between study days 1 and 7 and study days 8 and 14, the
participants took two measurements on the left wrist each
day in the morning between 6 and 9 a.m. and in the
evening between 8 and 9 p.m. after sitting for five minutesBMC Cardiovascular Disorders 2009, 9:20 http://www.biomedcentral.com/1471-2261/9/20
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with a two-minute interval between the two consecutive
measurements. Hypertensive subjects measured home BP
before taking antihypertensive medication. The antihy-
pertensive treatment regime was not changed during the
study period. Patients were instructed how to correctly use
the oscillometric Omron wrist device for home BP meas-
urement with a standardized 30 min. teaching program.
The blood pressure parameters of the first week (day 1 to
day 7) were compared with the results of the second week
(day 8 to day 14). The HEM- 637 IT wrist device is vali-
dated according to the international protocol of the Euro-
pean Society of Hypertension [9]. The home BP was
measured in accordance with the user procedures and rec-
ommendations of the European Society of Hypertension
[8].
3. Ambulatory 24-hour-blood pressure measurement (24-h ABPM)
The ambulatory 24-h blood pressure was performed
according to AHA and ESH guidelines and measured with
the ABPM 04 instrument of the company Meditech, Hun-
gary, on the left upper arm on study day 7 and 14. In the
period between 6 a.m. and 10 p.m., an oscillometric
blood pressure measurement was taken automatically at
intervals of 20 minutes, and at intervals of 45 minutes in
the period between 10 p.m. and 6 a.m. The CardioTens is
validated according to the BHS (British Hypertension
Society) protocol [10]
Echocardiography
On study day 1, a cardiac ultrasonographic investigation
was conducted in all patients with the Hewlett Packard
instrument (HP 5500, USA) with a 2.5 MHz transducer.
The left ventricular muscle mass index (LVMI) in g/m2
body surface was calculated in accordance with the cor-
rected Devereaux formula. LVMI was analysed by an
investigator blinded to the results of the BP measure-
ments.
Statistics
The parameters investigated were anthroprometric data
such as age, gender, height, body weight, body mass
index, circumference of the wrist and of the upper arm.
The parameters of office BP were systolic and diastolic
blood pressure and pulse pressure. The parameters of
home BP were systolic and diastolic blood pressure, heart
rate as well as pulse pressure. The parameters of the ambu-
latory 24-h ABPM were systolic and diastolic blood pres-
sure, heart rate, and pulse pressure measured, for the total
ambulatory 24 hour period, for the daytime (6 a.m. to 10
p.m.) and for the nighttime (10 p.m. to 6 a.m.).
Before the evaluation, the systolic and diastolic blood
pressure values were averaged for each method of meas-
urement (measurement in the doctor's office, 24-h meas-
urement and self-measurement) over the respective visit
to the doctor's office, day of measurement or the respec-
tive week of measurement. Consequently, two values
(mean values) were available for each of the methods.
These had been measured at an interval of about one
week. The mean values determined in this way were the
basis for the descriptive evaluation of the values measured
with the different methods.
In order to be able to compare the reproducibility of the
three measurement strategies, the standard deviation of
mean differences were compared. Student's t-test was used
to statistically compare the SD of mean difference
between measurement methods. Furthermore, the
squared differences between the first and second set of BP
measurements was calculated for office, home and 24-h
ABPM.
The left ventricular mass was used as a measure for the
extent of end organ damage and the correlation coeffi-
cient of the blood pressure parameters obtained with var-
ious methods of measurement with the left ventricular
mass index was calculated.
For each BP measurement method, the number of
patients needed to detect a two-sided α risk of 5% and a
statistical power of 80% to detect a systolic and diastolic
blood pressure difference of 5 mm Hg was calculated.
Results
The data from 97 patients were evaluated to compare the
reproducibility of blood pressure measurements. The cor-
relation analysis of blood pressure parameters with the
left ventricular mass index could only be carried out with
a subgroup of 74 patients in whom satisfactory sonogra-
phy was possible. The patients' characteristics are shown
in Table 1.
Compared to study days 1 and 7, there was no difference
in the office BP values. There was also no difference in the
home BP values, compared to week 1 and week 2, and no
diference in the 24-h ABPM values compared to study 7
and 14. The blood pressure values obtained with the dif-
ferent methods are shown in table 2.
Table 1: Patient characteristics
Range Mean SD
Age (years) 19–74 52 12
Height (cm) 153–199 173 9
Weight (kg) 52–128 81 17
BMI(kg/m2) 19–43 27 5
Left ventricular mass index (g/m2) 53–189 101 27
Left wrist circumference (cm) 13.5–20 17 2
Left upper arm circumference (cm) 23–41 30 3
SD: Standard deviationBMC Cardiovascular Disorders 2009, 9:20 http://www.biomedcentral.com/1471-2261/9/20
Page 4 of 9
(page number not for citation purposes)
The standard deviation of mean differences of the respec-
tive measurement method is shown in Table 3. This is a
measure for the reproducibility of the respective method
of measuring blood pressure.
For the three methods of blood pressure measurement,
the standard deviation of mean differences reveals that
home BP shows the least variability both for systolic and
diastolic BP. The reproducibility of systolic and diastolic
home BP was significantly higher than the reproducibility
of office BP (p = 0.001 systolic BP, and p < 0.001 diastolic
BP) and the reproducibility of 24-h ABPM (p < 0.001
systolic BP, p = 0.127 diastolic BP). The reproducibility of
systolic and diastolic office and 24-h ABPM was not signif-
icantly different (p = 0.8 systolic, p = 0.1 diastolic).
The squared differences for office, home BP and the 24-h
ABPM was analyzed as a further parameter for appraising
the reproducibility of the different methods of BP meas-
urement. The results are shown in figure 1a and 1b. Both
the variation for the systolic and the diastolic BP is lowest
for home BP measurement.
The results for reproducibility did not change, if a separate
analysis was performed for treated or untreated patients.
The correlation coefficient of the BP parameters of differ-
ent methods of measuring BP with the left ventricular
mass index is shown in figure 2. The correlation coeffi-
cient of 24-h ABMP systolic BP (r = 0.52) with left ven-
tricular mass index was significantly higher than with
systolic office BP (r = 0.31) (p = 0.035). The difference
between 24-h ABPM and home BP (r = 0.46) was not sig-
nificant (p = 0.456). The correlation coefficient with LVMI
was not significantly different between the three measure-
ment methods for diastolic BP (fig. 2)
For each blood pressure measurement method the
number of patients needed to detect a two-sided α risk of
5% and a statistical power of 80% a systolic and diastolic
blood pressure difference of 5 mm Hg is shown in table 4.
Discussion
In the present study, it could be shown that home BP
measurements at the wrist using a validated instrument
with activated position sensor show very much better
reproducibility not only compared to conventional office
BP measurements, but also compared to standardized 24-
h ABPM. Moreover, the coefficients of correlation with left
ventricular mass index as an indirect parameter of hyper-
tensive end organ damage were comparable with those of
home BP recently carried out on the upper arm and did
not differ significantly from those of 24-h ABPM.
As shown by earlier studies, the reproducibility of BP
measurements can be substantially increased by 24-h
ABPM compared to office BP [1,2,11]. However, the
reproducibility of 24-h ABPM was significantly superior to
home BP in previous studies [2]. A later investigation with
clinically validated home instruments and standardized
measurement protocols showed a distinctly better repro-
ducibility with home BP compared to office BP [4]. This is
taken to be essentially an effect of the larger number of
measurement values owing in home BP, an average of
approximately 28 self-measurements being made per
week depending on the measurement protocol. For exam-
ple the standard deviations of the mean difference
between two measurement periods can be used as an
expression of individual measurement variability. The
standard deviation of the mean difference both in 24-h
ABPM and in home BP essentially depends on the number
of measurements [12]. As has been shown by previous
studies, this standard deviation of the mean differences
for office BP is between 10 and 17 mmHg for systolic and
7–10 mmHg for diastolic values. This deviation is reduced
to 7–9 mmHg systolic and 5–7 mmHg diastolic by 24-h
ABPM. The scale of multiple home BP measurement and
their effect on this standard deviation is similar to that in
Table 2: Blood pressure values obtained with the different 
methods for the two measurement periods
Blood pressure (mmHg) Mean
systolic
SD Mean
diastolic
SD
Office BP Day 1 148 24 92 13
Office BP Day 7 144 21 90 12
Home BP Week 1 135 16 84 12
Home BP Week 2 134 16 83 12
24-h ABPM Day 7 131 15 79 11
24-h ABPM Day 14 133 16 80 11
24-h ABPM Daytime day 7 136 16 83 11
24-h ABPM Daytime day 14 137 17 84 12
SD: Standard deviation
Table 3: Standard deviation of the mean differences between the 
two measurement periods
systolic diastolic
SD 95% CI SD 95% CI
Home BP 3.81 3.34 – 4.44 2.77 2.43 – 3.22
24-h ABPM 7.83 6.90 – 9.17 4.09 3.59 – 4.77
Office BP 8.10 7.10 – 9.43 4.76 4.18 – 5.54
p- value
Home vers. 24-h ABPM p < 0.001 p = 0.127
Home vers. Office BP p < 0.001 p < 0.001
Office vers 24-h ABPM p = 0.80 p = 0.10
SD: Standard deviation of mean differences. 95% CI: 95% confidence 
interval.BMC Cardiovascular Disorders 2009, 9:20 http://www.biomedcentral.com/1471-2261/9/20
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Reproducibility of measurements shown as squared differences (y-axis) between the first and second set of blood pressure  (BP)measurements for Home BP, 24-h- ABPM and Office BP Figure 1
Reproducibility of measurements shown as squared differences (y-axis) between the first and second set of 
blood pressure (BP)measurements for Home BP, 24-h- ABPM and Office BP. Values are shown as box plots with 
median, 25/75 percentiles and minimum/maximum values. 1a: Squared systolic BP differences 1b.: Squared diastolic BP differ-
ences.
1a) 
 
1b) BMC Cardiovascular Disorders 2009, 9:20 http://www.biomedcentral.com/1471-2261/9/20
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24-h ABPM. Our working group found values of 5.4
mmHg for systolic and 4.3 mmHg for diastolic standard
deviations of the mean differences [4]. In a pharmacolog-
ical study in 1992, we were also able to show that the
reproducibility of upper-arm measurements at home was
better than that of office BP measurement, but also better
than standardized 24-h ABPM [13]. In this study, the sam-
ple size was very much reduced both compared to office
BP and also compared to 24-h ABPM [13]. In conse-
quence of this study as well as further studies, standard-
ized home BP have been accorded an ever greater
significance in clinical and pharmacological studies [14-
16].
Also in the present study, for each BP measurement
method, we have calculated the number of patients
needed to detect a two-sided α risk of 5% and a statistical
power of 80% to detect a systolic and diastolic blood pres-
sure difference of 5 mm Hg (table 4). The results of our
study indicate, that home blood pressure measurement
Correlation coefficient of the blood pressure parameters with the left ventricular mass index (LVMI) Figure 2
Correlation coefficient of the blood pressure parameters with the left ventricular mass index (LVMI). The cor-
relation coefficient of 24-h ABMP systolic BP (r = 0.52) with left ventricular mass index was significantly higher than with systo-
lic office BP (r = 0.31) (p = 0.035). The difference between 24-h ABPM and home BP (r = 0.46) was not significant (p = 0.456). 
The correlation coefficient with LVMI was not significantly different between the tree measurement methods for diastolic BP.BMC Cardiovascular Disorders 2009, 9:20 http://www.biomedcentral.com/1471-2261/9/20
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with a validated wrist device and activated position sensor
can improve the sensitivity of blood pressure measure-
ment in clinical trials by reducing the number of patients
needed to detect clinically significant differences in blood
pressure changes.
The present study was carried out with a validated wrist
blood pressure instrument with an activated position sen-
sor [17-19]. According to a recently published study, the
measurement precision of this system is further improved
by activation of the wrist position sensor [20]. However,
current recommendations from national and interna-
tional societies do not recommend wrist measurement as
the method of choice for performance of home BP
[21,22]. This is mainly due to the fact that numerous
imprecise and unvalidated wrist instruments were on the
market in the past. Moreover, the measurement precision
of wrist measurement is altered by the position of the
wrist in relation to that of the heart. Newer technologies
offer innovative approaches to improving the position of
measurement by use of an activated position sensor
[21,23]. Moreover, the system we used allows automatic
storage of all self-measured values, avoiding the familiar
errors of transfer in digital display or print-outs [24].
The standard deviations for the mean differences are
between 5 and 8 mmHg systolic and 4 and 6 mmHg
diastolic for home BP with upper-arm instruments. A
recently published study of Stergiou demonstrated that
the reproducibility was indeed even better with a newer
validated upper-arm instrument with digital print-outs
and standardized measurement than with a standardized
24-h ABPM [5]. The SD systolic and diastolic blood pres-
sures between the two sets of measurements also showed
that in this study home BP with a wrist instrument in
terms of reproducibility appeared to be superior to office
BP as well as 24-h ABPM.
The absolute number of values measured does not pro-
vide a cogent explanation for the better reproducibility of
home BP, since both in the first and in the second week an
average of 31 ± 7 and 31 ± 9 measurement values were
obtained of home BP as compared to 52+8 and 51 ± 8
measurement values in 24-h ABPM. It is more likely that
the largely standardized wrist measurement with auto-
matic recording of the values measured, activated position
sensor and measurements and defined times of day have
contributed to the very good reproducibility. Moreover,
fluctuations in BP which are not seen in 24-h ABPM but
might contribute to a raised variability are also detected
over a week with home BP. In our investigation, we have
also deliberately included the first day of home BP in the
analysis, since the patients were already familiar with the
instrument as a result of prior thorough instruction in
self-measurement at the wrist. However, the inclusion of
the first day in the measurement analysis did not affect the
reproducibility owing to the large number of measure-
ments.
Besides the reproducibility, the correlation of the different
methods of BP measurement with hypertensive end organ
damage measured with the left ventricular mass index was
also investigated in the present study. According to the
study results available so far, the 24-h ABPM shows corre-
lation coefficients with the left ventricular mass index of
0.52 for systolic and 0.46 for diastolic values [3,25,26].
Similar to the reproducibility, this better correlation with
end organ damage compared to the office BP is essentially
influenced by the greater number of measurements car-
ried out during 24-h ABPM. The day-night difference
which is detected with the 24-h ABPM does not contribute
substantially to the variability of the left ventricular mass
index [3]. Recently published studies have demonstrated
that multiple standardized measurements carried out by a
trained nurse in the hospital reveal similar coefficients of
correlation with the left ventricular mass index or the
intima media thickness of the carotid artery which are
similar to that of 24-h ABPM [27,28]. Earlier studies with
home BP have already shown a better correlation with
hypertensive end organ damage compared to office BP
[29-31]. The coefficients of correlation between home BP
and LVMI on the one hand and 24-h ABPM and LVMI on
the other hand calculated in the present study did not
reveal any significant differences. However there was
slight but not significant trent towards higher correlations
of LVMI with 24-h ABPM in the present study. The corre-
lation coefficients with LVMI determined with the wrist
instrument corresponded to those in recently published
upper-arm studies.
Conclusion
In this study, we attempted to include as large as possible
a spectrum of BP values in the range between optimal BP
values and hypertension of severity grade III. For this pur-
pose, we considered it necessary also to include in the
investigation patients under antihypertensive treatment
who were referred to our hospital because of hypertension
Table 4: Sensitivity of BP methods to measure significant BP 
changes
Number of Patients
Blood pressure method Systolic Diastolic
home BP 17 10
24-h ABPM 65 19
Office BP 64 23
Number of patients needed to detect a two-sided α risk of 5% and a 
statistical power of 80% a systolic and diastolic blood pressure 
difference of 5 mm Hg.BMC Cardiovascular Disorders 2009, 9:20 http://www.biomedcentral.com/1471-2261/9/20
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that was refractory to treatment. However, since the anti-
hypertensive medication remained unchanged over the
investigation period in all patients, an effect on one of the
methods of BP measurement would not have been
expected.
The present study did not address the question whether
home BP measurement with a wrist device with position
sensor is more or less reproducibile compared to an upper
arm device. In our view, the study design for such a study
would be very difficult to handle. Therefore, this question
may be evaluated in future studies
Furthermore, it was not our purpose to advocate the gen-
eral use of wrist devices. Such devices have physiological
limits with regards to accuracy and only devices with a
position sensor may be considered for clinical use [8].
Even though this wrist device was reproducible in the
research setting, it may be inaccurate if the instructions are
not strictly followed in the usual setting.
To summarize, the present study showed that the wrist
measurement of home BP with a validated system com-
prising an activated position sensor was superior in
respect of reproducibility both to office BP and 24-h
ABPM. Moreover, a correlation of the wrist measurement
with hypertensive end organ damage similar to that with
24-h ABPM was revealed. Although wrist devices have to
be used cautious and with defined limitations, the use of
validated devices with position sensor according to
recently recommended measurement schedules [9] might
have the potential to be used for therapy monitoring in
patients who prefer this method.
Competing interests
This study was supported by Omron Company, Japan.
The article-processing charge will be financed by Omron
Company
All authors declare that they have no competing interests
Authors' contributions
SU conceived of the study and its coordination, per-
formed the echocardiography, RF performed the statistical
analysis. MB recruited the patients, supplied blood pres-
sure measurements. GN drafted the manuscript, TM eval-
uated the echocardiography and drafted the manuscript.
All authors read and approved the final manuscript.
References
1. Coats A, Radaelli A, Clark S, Conway J, Sleight P: The influence of
ambulatory blood pressure monitoring on the design and
interpretation of trials in hypertension.  J Hypertens 1992,
10:385-391.
2. James GD, Pickering TG, Yee LS, Harshfield GA, Riva S, Laragh JH:
The reproducibility of average ambulatory, home, and clinic
pressures.  Hypertension 1988, 1:545-549.
3. Verdecchia P, Clement D, Fagard R, Palatini P, Parati G: Blood pres-
sure monitoring. Task force III: Target-organ damage, mor-
bidity and mortalità.  Blood Press Monit 1999, 4(6):303-17.
4. Mengden T, Battig B, Vetter W: Self-measurement of blood pres-
sure improves the accuracy and reduces the number of sub-
jects in clinical trials.  J Hypertens 1991, 9(suppl 6):336-337.
5. Stergiou G, Baibas N, Gantzarou A, Skeva I, Kalkana C, Roussias L,
Mountokalakis T: Reproducibility of home, ambulatory, and
clinic blood opressure: Implications for the design of trials
for the assessment of antihypertensive drug efficacy.  Am J
Hypertens 2002, 15:101-104.
6. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al.:
Recommendations for blood pressure measurement in
humans and experimental animals. Part 1: Blood pressure
measurement in humans.  Circulation 2005, 111(5):697-716.
7. Kikuya M, Chonan K, Imai Y, Goto E, Ishii M: Accuracy and relia-
bility of wrist-cuff devices for selfmeasurement.  J Hypertens
2002, 20:629-38.
8. O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, Myers M,
Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Ster-
giou G, Verdecchia P, On behalf of the European Society of Hyperten-
sion Working Group on Blood Pressure Monitoring: Practice
Guidelines of the European Society of Hypertension for
Clinic, Ambulatory, and Self Blood Pressure Measurement.
J Hypertens 2005, 23(4):697-701.
9. Topouchian JA, El Assaad MA, Orobinskaia LV, El Feghali LN, Asmar
RG: Validation of two automatic devices for self-measure-
ment of blood pressure according to the International Pro-
tocol of the European Society of Hypertension: the Omron
M6 (HEM-7001-E) and the Omron R7 (HEM-637-IT).  Blood
Press Monit 2006, 11:165-171.
10. Barna I, Keszei A, Dunai A: Evaluation of Meditech ABPM-04
ambulatory BP measuring device according to the British
Hypertension Society protocol.  Blood Press Monit 1998,
3:363-368.
11. Trazzi S, Mutti E, Frattola A, Imholz B, Parati G, Mancia G: Repro-
ducibility of non-invasive and intra-arterial blood pressure
monitoring: implications for studies on antihypertensive
drugs.  J Hypertens 1991, 9:115-119.
12. Chatellier G, Day M, Bodrie G, Menard J: Feasibility study of n-of-
1 trials with blood pressure self-monitoring in hypertension.
Hypertension 1995, 25:294-301.
13. Mengden T, Binswanger B, Weisser B, Vetter W: An evaluation of
self-measured blood pressure in a study with calcium-chan-
nel antagonist versus β-blocker.  Am J Hypertens 1992, 5:154-160.
14. Ragot S, Genès N, Vaur L, Herpin D: Comparison of three blood
pressure measurement methods for the evaluation of two
antihypertensive drugs: Feasibility, agreement, and repro-
ducibility of blood pressure response.  Am J Hypertens 2000,
13:632-639.
15. Baguet JP, Mallion JM: Self-monitoring of blood pressure should
be used in clinical trials.  Blood Press Monit 2002, 7:55-59.
16. Mengden T, Ewald S, Kaufmann S, vor dem Esche J, Uen S, Vetter H:
Telemonitoring of blood pressure self measurement in the
OLMETEL study.  Blood Press Monit (England) 2004, 9(6):.
17. Altunkan S, Öztas K, Altunkan E: Validation of the Omron 637IT
wrist blood pressure measuring device with a position sensor
according to the international protocol in adults and obese
adults.  Blood Press Monit 2006, 11:79-85.
18. Altunkan S, Altunkan E: Validation of the Omron 637IT wrist
blood pressure measuring device with a position sensor
according to the international protocol in the elderly.  Blood
Press Monit 2006, 11:97-102.
19. Altunkan S, Genc Y, Altunkan E: A comparative study of an
ambulatory blood pressure measuring device and a wrist
blood pressure monitor with a position sensor versus a mer-
cury sphygmomanometer.  Eur J Intern Med 2007, 18(2):118-23.
20. Yarows S: Comparison of the Omron HEM-637 wrist monitor
to the auscultation method with the wrist postion sensor on
or disabled.  Am J Hypertens 2004, 17:54-58.
21. World Health Organization, International Society of Hypertension
Writing Group: World Health Organization (WHO)/Interna-Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Cardiovascular Disorders 2009, 9:20 http://www.biomedcentral.com/1471-2261/9/20
Page 9 of 9
(page number not for citation purposes)
tional Society of Hypertension (ISH) statement on manage-
ment of hypertension.  J Hypertens 2003, 21:1983-92.
22. O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, Myers M,
et al.: Practice guidelines of the European Society of Hyper-
tension for clinic, ambulatory and self blood pressure meas-
urement.  J Hypertens 2005, 23(4):697-701.
23. Uen S, Weisser B, Wieneke P, Vetter H, Mengden M: Evaluation of
the performance of a wrist blood pressure measuring device
with a position sensor compared to ambulatory 24-h blood
pressure measurements.  Am J Hypertens (United States) 2002,
15(9):787-92.
24. Mengden T, Hernandez Medina RM, Beltran B, Alvarez E, Kraft K,
Vetter H: Reliability of reporting self-measured blood pres-
sure values by hypertensive patients.  Am J Hypertens 1998,
11:1413-1417.
25. Kok RH, Beltman FW, Terpstra WF, Smit AJ, May JF, de Graeff PA,
Meyboom-de Jong B: Home blood pressure measurement:
reproducibility and relationship with left ventricular mass.
Blood Press Monit 1999, 4(2):65-9.
26. Fagard R, Staessen JA, Thijs L: The relationships between left
ventricular mass and daytime and night-time blood pres-
sures: a meta-analysis of comparative studies.  J Hypertens
1995, 13:823-9.
27. Iula A, Puukka P, Karanko A: Multiple clinic and home blood
pressure measurements versus ambulatory blood pressure
monitoring.  Hypertension 1999, 34:261-266.
28. Nyström F, Malmqvist K, Lind L, Kahan T: Nurse-recorded clinic
and ambulatory blood pressures correlate equally well with
left ventricular mass and carotid intima-media thickness.  J I
M 2005, 257:514-522.
29. Ibrahim MM, Tarazi RC, Dustan HP, Gifford RW: Electrocardio-
gram in evaluation of resistance to antihypertensive therapy.
Arch Intern Med 1977, 137:15-18.
30. Kleinert HD, Harshlfield GA, Pickering TG, Devereux RB, Sullivan PA,
Marlon RM, et al.: What is the value of home blood pressure
measurement in patients with mild hypertension?  Hyperten-
sion 1984, 6:574-578.
31. Abé H, Yokouchi M, Nagata S, Ashida T, Yoshimi H, Kawano Y,
Kojima S, Matsuoka S, Kuramochi M, Omae T: Relation of office
and home blood pressure to left ventricular hypertrophy and
performance in patients with hypertension.  High Blood Press
1992, 1:279-285.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2261/9/20/prepub